ERBB2 and ovarian cancer: While not much research has been focused on the use of Herceptin in treating ovarian cancer, there may be a subset of ovarian cancer patients with HER2 overexpression that may benefit from Herceptin incorporated into their treatment plan, but this needs to be explored in greater detail.